Immunology
Structure-based vaccine design may help save the lives of infants and children
A new experimental vaccine, utilizing structure-based design, shows promise in a phase I clinical trial. The vaccine will protect against respiratory syncytial virus (RSV), a leading cause of infectious disease deaths in infants. Researchers at the University of Texas at Austin published findings on Aug 2, 2019 in Science stating that one dose elicited increases in RSV-neutralizing antibodies over several months.  Discuss
The European Commission pursues open science and why it’s important
Scientists believe that there is a reproducibility crisis in the scientific community where many scientists fail to reproduce experiments, according to a new report by Science | Business in July 2019. Open science is a high priority for the European Commission, with around 70% of all data generated by EU-funded programs being accessible to the public.  Discuss
CAR-T cell therapy research shows encouraging signs for mesothelioma patients
Every year, nearly 3,000 new cases of mesothelioma are diagnosed in the United States. While this is just a small percentage of overall cancer diagnoses, this rare cancer is one that has proven to be extremely difficult to treat. Fortunately, even with this cancer affecting a disproportionate number of patients, researchers are continuing to study mesothelioma in hopes of improving the disease’s prognosis.  Discuss
Landmark study explores public understanding of science and trust in scientific and medical professionals
Understanding global perceptions and knowledge of science is of growing interest to the scientific community. Organizations such as 3M, with their State of Science Index Survey and the Wellcome Global Monitor (WGM), from the Wellcome Foundation and Gallup World Poll, explore attitudes towards science and medicine, and also confidence in scientists themselves.  Discuss
Leaders in science and engineering publications over the last decade: China and the US
Capturing the attention of policy makers and companies serving the academic research market the countries with the largest number of science and engineering (S&E) articles has significantly evolved between 2007 and 2017. China leads the list in 2017 followed by the US, a reverse from 2007, according to a May report from the NSF’s National Center for Science and Engineering Statistics.  Discuss
The National Institutes of Health launches the Symptom Science Center
The National Institutes of Health, National Institute of Nursing Research (NIH NINR) launched the Symptom Science Center on June 27th, 2019 at the NIH Campus in Bethesda, MD. This event, attended by over 500 individuals, marks a momentous occasion for both clinical and translational multidisciplinary research.  Discuss
Purchasing products: Experiences with scientists and suppliers
Recently, we asked over 900 members of the SAB to tell us more about how they purchase products through life science suppliers, and the factors that influence their selection of supplier.  Discuss
Customer service and technical support: From your perspective
Over 700 members of the SAB recently took part in a survey regarding their experiences with customer service and technical support through life science suppliers. We thought you’d like to know a little more about some of the results from this project, to understand how some of the research we conduct with your help ends up!  Discuss
UK Scientists Weigh In on Brexit and Laboratory Spending - Science Advisory Board Insights
The long road to a resolution of the Brexit situation appeared to be nearing an end earlier this year, with the deadline set for March 29 to finalize how Britain would exit the EU. A “hard” Brexit, the case if no EU-Britain agreement is reached, would remove Britain from the EU’s single market among other consequences. A “soft” exit would result in Britain remaining part of the single market, but not an EU member. With a government stalemate in Britain, the EU agreed to extend the deadline until October 31, though a deal may come sooner.  Discuss
The Promise of Targeted Therapeutics in Cancer Treatment
In 2018, the International Agency for Research on Cancer reported more than 18 million people were diagnosed with cancer. Between 40 and 45 million people worldwide are living with cancer and nearly 9.6 million people die. Cancer deaths occur in about 50% of people who develop cancer in developed countries; this is in contrast to 80% death rate in cancer patients in underdeveloped countries. The numbers are staggering. But there is hope, as scientists around the globe work on developing new technologies, in the form of targeted therapies, to combat the incidence of cancer.  Discuss
Conferences
Society for Laboratory Automation and Screening (SLAS) 2020
January 25-29
San Diego, California United States
American Society for Microbiology (ASM) Biothreats
January 28-30
Arlington, Virginia United States
Festival of Genomics 2020
January 29-30
London, Greater London United Kingdom
Medlab Middle East
February 3-6
Dubai, Dubai United Arab Emirates
General Discussion
Topic Replies / Views Last Update
Open science for the modern scientific community
by LMoraes
1 / 19 More than 3 days ago
by Prof. Salvatore Parisi
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 5 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 3 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 13 More than 3 days ago
by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
by Mahesh Gupta
0 / 13 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter